Alzamend Neuro, Inc. (ALZN) — Institutional Holders, Q2 2026
12 institutional investment managers reported a ALZN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ALZN in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- KMT WEALTH MANAGEMENTNew · +1,329,100 sh+$1.6M
- Kingsbury Capital Investment AdvisorsAdded · +762,367 sh+$914.8K
- VANGUARD CAPITAL MANAGEMENTAdded · +3,156 sh+$3.8K
- IFG AdvisoryNew · +22 sh+$26.00
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -19,309 sh-$23.2K
- MORGAN STANLEYSold out · -18,000 sh-$21.6K
- Clearstead AdvisorsSold out · -10,000 sh-$12.0K
- CITIGROUPSold out · -5,231 sh-$6.3K
- Tower Research Capital (TRC)Trimmed · -2,667 sh-$3.2K
ALZN 13F holders ranked 1–12 of 12
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Kingsbury Capital Investment Advisors#1 · 1,329,100 sh | 1,329,100 | $1.6M | — | +134.5% |
| 2 | KMT WEALTH MANAGEMENT#2 · 1,329,100 sh | 1,329,100 | $1.6M | 1.35% | New |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 26,371 sh | 26,371 | $31.6K | 0.00% | -42.3% |
| 4 | VANGUARD FIDUCIARY#4 · 21,020 sh | 21,020 | $25.2K | 0.00% | 0.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT#5 · 7,556 sh | 7,556 | $9.1K | 0.00% | +71.7% |
| 6 | Tower Research Capital (TRC)#6 · 3,517 sh | 3,517 | $4.2K | <0.01% | -43.1% |
| 7 | UBS Group AG#7 · 2,352 sh | 2,352 | $2.8K | 0.00% | -47.8% |
| 8 | BlackRock#8 · 437 sh | 437 | $524.00 | 0.00% | 0.0% |
| 9 | IFG Advisory#9 · 22 sh | 22 | $26.00 | 0.00% | New |
| 10 | SBI Securities , Ltd.#10 · 22 sh | 22 | $26.00 | — | 0.0% |
| 11 | Caitong International Asset Management , Ltd#11 · 3 sh | 3 | $4.00 | 0.00% | -25.0% |
| 12 | HARBOR INVESTMENT ADVISORY#12 · 1 sh | 1 | $1.00 | — | 0.0% |
Funds that sold out of ALZN in Q2 2026 (3)
Held ALZN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| MORGAN STANLEY18,000 sh | 18,000 | $19.1K |
| Clearstead Advisors10,000 sh | 10,000 | $10.6K |
| CITIGROUP5,231 sh | 5,231 | $5.5K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.